Hubertus von Baumbach

Hubertus von Baumbach
Born	1966or1967(age 58–59) [1]
Nationality	German
Occupation	Businessman
Title	Chairman and CEO, Boehringer Ingelheim

Hubertus von Baumbach (born 1967) is a German businessman who is the chairman and CEO of Boehringer Ingelheim, Germany's second largest pharmaceutical company. ^[2]

Early life and education

The son of Erich von Baumbach and Ulrike Boehringer, Hubertus von Baumbach is also a great-grandson of the company's founder Albert Boehringer. ^[1]

Career

Baumbach joined Boehringer Ingelheim in 2001. ^[3]

In November 2015, it was announced that Baumbach, who had been CFO, was appointed as chief executive, succeeding Andreas Barner in June 2016. ^{[1] [2]} At the time, this made him the first member of the family at the helm in 25 years. ^[4] Within his first six months, he launched the biggest acquisition in the company's history (an asset swap deal with French rival Sanofi), followed by a reorganization to give the group a more decentralized divisional structure. ^[5]

In his capacity at Boehringer Ingelheim, Baumbach was part of Chancellor Angela Merkel’s delegation on three state visits to China. ^[6]

Other activities

Corporate boards

• Deutsche Bank, Member of the Advisory Board ^[7]
• Baden-Württembergische Bank, Member of the Advisory Board
• Landesbank Baden-Württemberg (LBBW), Member of the Advisory Board ^[8]
• KWS Saat, Member of the supervisory board (2007-2017)

Non-profit organizations

• Federation of German Industries (BDI), Member of the Presidium (2018-2019) ^[9]
• German Chemical Industry Association (VCI), Member of the Executive Committee ^[10]
• Baden-Badener Unternehmer-Gespräche (BBUG), Member of the Board of Trustees ^[11]
• Cultural Foundation of the Federal States, Member of the Board of Trustees ^[12]
• Städel Museum, Member of the Administration ^[13] and the Board of Trustees ^[14]
• Stiftung Tausendgut, Member of the Board of Trustees ^[15]

References

1. "Boehringer appoints first CEO from founding family in 25 years". reuters.com. 6 November 2015. Retrieved 7 November 2018.
2. "Drug firm Boehringer Ingelheim on a high". handelsblatt.com. 27 April 2018. Retrieved 7 November 2018.
3. "Board of Managing Directors - boehringer-ingelheim.com". boehringer-ingelheim.com. Retrieved 7 November 2018.
4. Patricia Weiss and Maria Sheahan (November 6, 2015), Boehringer appoints first CEO from founding family in 25 years Reuters .
5. Siegfried Hofmann (April 27, 2018), Drug firm Boehringer Ingelheim on a high Handelsblatt .
6. Christian Schlesiger (September 8, 2017), Siemens-Chef Kaeser am häufigsten bei Delegationsreisen dabei Wirtschaftswoche .
7. Members of the Advisory Board, 2010 Deutsche Bank.
8. 2015 Annual Report Landesbank Baden-Württemberg (LBBW).
9. Presidium Federation of German Industries (BDI).
10. "Vorstand & Präsidium - Verband der Chemischen Industrie e.V. (VCI)". www.vci.de (in German). Retrieved 2017-06-01.
11. Board of Trustees Archived 2018-01-09 at the Wayback Machine Baden-Badener Unternehmer-Gespräche (BBUG).
12. Board of Trustees Cultural Foundation of the Federal States.
13. Administration Städel Museum.
14. Board of Trustees Städel Museum.
15. Board of Trustees Stiftung Tausendgut.